Clindamycin Therapy
Clindamycin Therapy is a pharmacotherapeutic intervention that involves the administration of the lincosamide antibiotic clindamycin to target Gram-positive and anaerobic pathogens in sepsis management, distinguished by its unique spectrum of antimicrobial activity and role in modulating toxin production in specific bacterial infections.
1.7K
Publications
78.9K
Citations
6.5K
Authors
1.8K
Institutions
Publications per year
2017–2026
224
Parents
1.7K
Clindamycin-Associated Colitis
Francis J. Tedesco · Annals of Internal Medicine · 1974 · 610 citations
1–5 of 1.7K
6.5K
13
h-index
12
h-index
Penn State Milton S. Hershey Medical Center, United States
10 publications · 331 citations
10
h-index
9
h-index
9
h-index
1–5 of 6.5K
1.8K
University of Michigan
Ann Arbor, United States
21 h-index
119 publications
8.5K citations
United States Department of Veterans Affairs
Washington, United States
21 h-index
64 publications
3.8K citations

Karolinska Institutet
Stockholm, Sweden
19 h-index
64 publications
4.4K citations
University of Washington
Seattle, United States
18 h-index
56 publications
3.6K citations
University of California, San Francisco
San Francisco, United States
18 h-index
67 publications
3.2K citations

Centers for Disease Control and Prevention
Atlanta, United States
18 h-index
59 publications
6.8K citations
W.E. Upjohn Institute for Employment Research
Kalamazoo, United States
17 h-index
73 publications
2.2K citations

Johns Hopkins University
Baltimore, United States
16 h-index
42 publications
4K citations
1–8 of 1.8K
AAC · 178 publications · 8.2K citations
52
h-index
Repository · 223 publications · 6.2K citations
38
h-index
JID · 55 publications · 4.3K citations
36
h-index
CID · 57 publications · 5.1K citations
35
h-index
JAC · 83 publications · 2.8K citations
30
h-index
1–5